Australia markets closed

Benitec Biopharma Inc. (BNTC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
9.22-0.43 (-4.49%)
As of 02:30PM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
7
75
73
59
97
Cost of revenue
-
0
9
123
-185
Gross profit
-
75
64
-64
282
Operating expenses
Research development
15,283
12,774
11,272
7,020
3,001
Selling general and administrative
6,324
6,382
6,646
6,512
5,567
Total operating expenses
21,499
19,156
17,927
13,655
8,378
Operating income or loss
-21,492
-19,081
-17,854
-13,596
-8,281
Interest expense
24
33
32
6
-
Total other income/expenses net
-176
-448
-322
-280
-55
Income before tax
-21,692
-19,562
-18,208
-13,882
-8,274
Income from continuing operations
-21,692
-19,562
-18,208
-13,882
-8,274
Net income
-21,692
-19,562
-18,208
-13,882
-8,274
Net income available to common shareholders
-21,692
-19,562
-18,208
-13,882
-8,274
Basic EPS
-234.82
-240.04
-643.96
-54.91
-137.70
Diluted EPS
-234.82
-240.04
-643.96
-54.91
-137.70
Basic average shares
461.141
81.518
28.275
252.671
60.07
Diluted average shares
461.141
81.518
28.275
252.671
60.07